nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—NFKB1—rheumatoid arthritis	0.322	0.689	CbGaD
Thalidomide—TNF—rheumatoid arthritis	0.0986	0.211	CbGaD
Thalidomide—PTGS2—rheumatoid arthritis	0.0468	0.1	CbGaD
Thalidomide—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0285	0.112	CbGbCtD
Thalidomide—PTGS2—Triamcinolone—rheumatoid arthritis	0.0285	0.112	CbGbCtD
Thalidomide—PTGS2—Betamethasone—rheumatoid arthritis	0.0244	0.0961	CbGbCtD
Thalidomide—PTGS1—Sulfasalazine—rheumatoid arthritis	0.024	0.0946	CbGbCtD
Thalidomide—CYP1A2—Leflunomide—rheumatoid arthritis	0.0174	0.0684	CbGbCtD
Thalidomide—CYP2C9—Leflunomide—rheumatoid arthritis	0.0157	0.0616	CbGbCtD
Thalidomide—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0144	0.0568	CbGbCtD
Thalidomide—PTGS2—Dexamethasone—rheumatoid arthritis	0.0142	0.0559	CbGbCtD
Thalidomide—CYP1A1—Dexamethasone—rheumatoid arthritis	0.012	0.0472	CbGbCtD
Thalidomide—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0116	0.0456	CbGbCtD
Thalidomide—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0109	0.043	CbGbCtD
Thalidomide—CYP2C19—Prednisone—rheumatoid arthritis	0.00931	0.0366	CbGbCtD
Thalidomide—CYP2E1—Dexamethasone—rheumatoid arthritis	0.00927	0.0365	CbGbCtD
Thalidomide—CYP2C19—Cyclosporine—rheumatoid arthritis	0.00882	0.0347	CbGbCtD
Thalidomide—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00733	0.0289	CbGbCtD
Thalidomide—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0072	0.0283	CbGbCtD
Thalidomide—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00581	0.0229	CbGbCtD
Thalidomide—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00483	0.019	CbGbCtD
Thalidomide—Lenalidomide—TNFSF11—rheumatoid arthritis	0.00266	0.571	CrCbGaD
Thalidomide—FGFR2—exocrine gland—rheumatoid arthritis	0.00169	0.0852	CbGeAlD
Thalidomide—PTGS2—skeletal joint—rheumatoid arthritis	0.00141	0.0709	CbGeAlD
Thalidomide—NFKB1—parotid gland—rheumatoid arthritis	0.00117	0.059	CbGeAlD
Thalidomide—NFKB1—saliva-secreting gland—rheumatoid arthritis	0.00112	0.0566	CbGeAlD
Thalidomide—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.00107	0.0539	CbGeAlD
Thalidomide—NFKB1—connective tissue—rheumatoid arthritis	0.00103	0.052	CbGeAlD
Thalidomide—CRBN—parotid gland—rheumatoid arthritis	0.000984	0.0495	CbGeAlD
Thalidomide—PTGS2—cartilage tissue—rheumatoid arthritis	0.000948	0.0477	CbGeAlD
Thalidomide—CRBN—saliva-secreting gland—rheumatoid arthritis	0.000942	0.0474	CbGeAlD
Thalidomide—FGFR2—saliva-secreting gland—rheumatoid arthritis	0.000844	0.0425	CbGeAlD
Thalidomide—FGFR2—connective tissue—rheumatoid arthritis	0.000776	0.039	CbGeAlD
Thalidomide—NFKB1—lymphoid tissue—rheumatoid arthritis	0.000755	0.038	CbGeAlD
Thalidomide—NFKB1—digestive system—rheumatoid arthritis	0.000746	0.0375	CbGeAlD
Thalidomide—NFKB1—tendon—rheumatoid arthritis	0.00071	0.0357	CbGeAlD
Thalidomide—Menadione—BGLAP—rheumatoid arthritis	0.000698	0.15	CrCbGaD
Thalidomide—CRBN—lymphoid tissue—rheumatoid arthritis	0.000633	0.0318	CbGeAlD
Thalidomide—CRBN—digestive system—rheumatoid arthritis	0.000625	0.0315	CbGeAlD
Thalidomide—CRBN—tendon—rheumatoid arthritis	0.000595	0.0299	CbGeAlD
Thalidomide—FGFR2—digestive system—rheumatoid arthritis	0.00056	0.0282	CbGeAlD
Thalidomide—Pomalidomide—TNF—rheumatoid arthritis	0.000506	0.109	CrCbGaD
Thalidomide—CYP1A1—parotid gland—rheumatoid arthritis	0.000319	0.016	CbGeAlD
Thalidomide—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000301	0.159	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000297	0.156	CbGdCrCtD
Thalidomide—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000297	0.156	CbGdCrCtD
Thalidomide—Menadione—MTHFR—rheumatoid arthritis	0.000294	0.0632	CrCbGaD
Thalidomide—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.00029	0.153	CbGdCrCtD
Thalidomide—Lenalidomide—PTGS2—rheumatoid arthritis	0.000258	0.0555	CrCbGaD
Thalidomide—CYP2C19—digestive system—rheumatoid arthritis	0.000252	0.0127	CbGeAlD
Thalidomide—PTGS1—connective tissue—rheumatoid arthritis	0.000247	0.0124	CbGeAlD
Thalidomide—Pomalidomide—PTGS2—rheumatoid arthritis	0.00024	0.0516	CrCbGaD
Thalidomide—PTGS2—connective tissue—rheumatoid arthritis	0.000236	0.0119	CbGeAlD
Thalidomide—CYP1A2—digestive system—rheumatoid arthritis	0.000206	0.0103	CbGeAlD
Thalidomide—CYP1A1—digestive system—rheumatoid arthritis	0.000203	0.0102	CbGeAlD
Thalidomide—CYP3A5—digestive system—rheumatoid arthritis	0.000198	0.00997	CbGeAlD
Thalidomide—CYP2C9—digestive system—rheumatoid arthritis	0.000195	0.00982	CbGeAlD
Thalidomide—CYP2E1—lymphoid tissue—rheumatoid arthritis	0.000187	0.00942	CbGeAlD
Thalidomide—CYP2E1—digestive system—rheumatoid arthritis	0.000185	0.0093	CbGeAlD
Thalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000182	0.0958	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000179	0.0943	CbGdCrCtD
Thalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000179	0.0943	CbGdCrCtD
Thalidomide—PTGS1—digestive system—rheumatoid arthritis	0.000178	0.00896	CbGeAlD
Thalidomide—CYP2E1—tendon—rheumatoid arthritis	0.000176	0.00885	CbGeAlD
Thalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000175	0.0921	CbGdCrCtD
Thalidomide—PTGS2—lymphoid tissue—rheumatoid arthritis	0.000172	0.00867	CbGeAlD
Thalidomide—PTGS2—digestive system—rheumatoid arthritis	0.00017	0.00857	CbGeAlD
Thalidomide—PTGS1—tendon—rheumatoid arthritis	0.00017	0.00853	CbGeAlD
Thalidomide—PTGS2—tendon—rheumatoid arthritis	0.000162	0.00815	CbGeAlD
Thalidomide—Hypotension—Methylprednisolone—rheumatoid arthritis	3.64e-05	0.000282	CcSEcCtD
Thalidomide—Pain—Prednisolone—rheumatoid arthritis	3.63e-05	0.000281	CcSEcCtD
Thalidomide—Hepatitis—Methotrexate—rheumatoid arthritis	3.63e-05	0.000281	CcSEcCtD
Thalidomide—Decreased appetite—Hydrocortisone—rheumatoid arthritis	3.6e-05	0.000279	CcSEcCtD
Thalidomide—Pharyngitis—Methotrexate—rheumatoid arthritis	3.6e-05	0.000279	CcSEcCtD
Thalidomide—Nausea—Leflunomide—rheumatoid arthritis	3.59e-05	0.000278	CcSEcCtD
Thalidomide—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.58e-05	0.000277	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.58e-05	0.000277	CcSEcCtD
Thalidomide—Fatigue—Hydrocortisone—rheumatoid arthritis	3.57e-05	0.000277	CcSEcCtD
Thalidomide—Vision blurred—Prednisone—rheumatoid arthritis	3.56e-05	0.000276	CcSEcCtD
Thalidomide—Urethral disorder—Methotrexate—rheumatoid arthritis	3.55e-05	0.000275	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3.55e-05	0.000275	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	3.55e-05	0.000275	CcSEcCtD
Thalidomide—Pain—Hydrocortisone—rheumatoid arthritis	3.54e-05	0.000274	CcSEcCtD
Thalidomide—Oedema—Dexamethasone—rheumatoid arthritis	3.54e-05	0.000274	CcSEcCtD
Thalidomide—Oedema—Betamethasone—rheumatoid arthritis	3.54e-05	0.000274	CcSEcCtD
Thalidomide—Insomnia—Triamcinolone—rheumatoid arthritis	3.53e-05	0.000273	CcSEcCtD
Thalidomide—Insomnia—Methylprednisolone—rheumatoid arthritis	3.52e-05	0.000273	CcSEcCtD
Thalidomide—Infection—Dexamethasone—rheumatoid arthritis	3.52e-05	0.000272	CcSEcCtD
Thalidomide—Infection—Betamethasone—rheumatoid arthritis	3.52e-05	0.000272	CcSEcCtD
Thalidomide—Ill-defined disorder—Prednisone—rheumatoid arthritis	3.5e-05	0.000271	CcSEcCtD
Thalidomide—Paraesthesia—Triamcinolone—rheumatoid arthritis	3.5e-05	0.000271	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisolone—rheumatoid arthritis	3.49e-05	0.000271	CcSEcCtD
Thalidomide—Paraesthesia—Methylprednisolone—rheumatoid arthritis	3.49e-05	0.000271	CcSEcCtD
Thalidomide—Visual impairment—Methotrexate—rheumatoid arthritis	3.49e-05	0.000271	CcSEcCtD
Thalidomide—Anaemia—Prednisone—rheumatoid arthritis	3.49e-05	0.00027	CcSEcCtD
Thalidomide—Shock—Betamethasone—rheumatoid arthritis	3.48e-05	0.00027	CcSEcCtD
Thalidomide—Shock—Dexamethasone—rheumatoid arthritis	3.48e-05	0.00027	CcSEcCtD
Thalidomide—Dyspnoea—Triamcinolone—rheumatoid arthritis	3.48e-05	0.000269	CcSEcCtD
Thalidomide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	3.47e-05	0.000269	CcSEcCtD
Thalidomide—Nervous system disorder—Betamethasone—rheumatoid arthritis	3.47e-05	0.000269	CcSEcCtD
Thalidomide—Agitation—Prednisone—rheumatoid arthritis	3.47e-05	0.000269	CcSEcCtD
Thalidomide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.46e-05	0.000268	CcSEcCtD
Thalidomide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.46e-05	0.000268	CcSEcCtD
Thalidomide—Tachycardia—Betamethasone—rheumatoid arthritis	3.45e-05	0.000268	CcSEcCtD
Thalidomide—Tachycardia—Dexamethasone—rheumatoid arthritis	3.45e-05	0.000268	CcSEcCtD
Thalidomide—Angioedema—Prednisone—rheumatoid arthritis	3.45e-05	0.000267	CcSEcCtD
Thalidomide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	3.43e-05	0.000266	CcSEcCtD
Thalidomide—Dyspepsia—Triamcinolone—rheumatoid arthritis	3.43e-05	0.000266	CcSEcCtD
Thalidomide—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.43e-05	0.000266	CcSEcCtD
Thalidomide—Dyspepsia—Methylprednisolone—rheumatoid arthritis	3.43e-05	0.000265	CcSEcCtD
Thalidomide—Hyperhidrosis—Betamethasone—rheumatoid arthritis	3.42e-05	0.000265	CcSEcCtD
Thalidomide—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	3.42e-05	0.000265	CcSEcCtD
Thalidomide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.41e-05	0.000264	CcSEcCtD
Thalidomide—Malaise—Prednisone—rheumatoid arthritis	3.41e-05	0.000264	CcSEcCtD
Thalidomide—Vertigo—Prednisone—rheumatoid arthritis	3.39e-05	0.000263	CcSEcCtD
Thalidomide—Eye disorder—Methotrexate—rheumatoid arthritis	3.39e-05	0.000262	CcSEcCtD
Thalidomide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.39e-05	0.000262	CcSEcCtD
Thalidomide—Syncope—Prednisone—rheumatoid arthritis	3.39e-05	0.000262	CcSEcCtD
Thalidomide—Tinnitus—Methotrexate—rheumatoid arthritis	3.38e-05	0.000262	CcSEcCtD
Thalidomide—Anorexia—Dexamethasone—rheumatoid arthritis	3.37e-05	0.000261	CcSEcCtD
Thalidomide—Anorexia—Betamethasone—rheumatoid arthritis	3.37e-05	0.000261	CcSEcCtD
Thalidomide—Urticaria—Prednisolone—rheumatoid arthritis	3.37e-05	0.000261	CcSEcCtD
Thalidomide—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.36e-05	0.000261	CcSEcCtD
Thalidomide—Fatigue—Triamcinolone—rheumatoid arthritis	3.36e-05	0.00026	CcSEcCtD
Thalidomide—Fatigue—Methylprednisolone—rheumatoid arthritis	3.36e-05	0.00026	CcSEcCtD
Thalidomide—Asthenia—Cyclosporine—rheumatoid arthritis	3.34e-05	0.000259	CcSEcCtD
Thalidomide—Pain—Triamcinolone—rheumatoid arthritis	3.34e-05	0.000258	CcSEcCtD
Thalidomide—Loss of consciousness—Prednisone—rheumatoid arthritis	3.32e-05	0.000257	CcSEcCtD
Thalidomide—Hypotension—Dexamethasone—rheumatoid arthritis	3.31e-05	0.000256	CcSEcCtD
Thalidomide—Hypotension—Betamethasone—rheumatoid arthritis	3.31e-05	0.000256	CcSEcCtD
Thalidomide—Pruritus—Cyclosporine—rheumatoid arthritis	3.3e-05	0.000255	CcSEcCtD
Thalidomide—Urticaria—Hydrocortisone—rheumatoid arthritis	3.29e-05	0.000255	CcSEcCtD
Thalidomide—Angiopathy—Methotrexate—rheumatoid arthritis	3.29e-05	0.000255	CcSEcCtD
Thalidomide—Immune system disorder—Methotrexate—rheumatoid arthritis	3.27e-05	0.000254	CcSEcCtD
Thalidomide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.27e-05	0.000254	CcSEcCtD
Thalidomide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.27e-05	0.000254	CcSEcCtD
Thalidomide—Convulsion—Prednisone—rheumatoid arthritis	3.27e-05	0.000253	CcSEcCtD
Thalidomide—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.27e-05	0.000253	CcSEcCtD
Thalidomide—Hypertension—Prednisone—rheumatoid arthritis	3.26e-05	0.000253	CcSEcCtD
Thalidomide—Chills—Methotrexate—rheumatoid arthritis	3.25e-05	0.000252	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3.22e-05	0.00025	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3.22e-05	0.00025	CcSEcCtD
Thalidomide—Myalgia—Prednisone—rheumatoid arthritis	3.21e-05	0.000249	CcSEcCtD
Thalidomide—Arthralgia—Prednisone—rheumatoid arthritis	3.21e-05	0.000249	CcSEcCtD
Thalidomide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	3.21e-05	0.000249	CcSEcCtD
Thalidomide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	3.21e-05	0.000248	CcSEcCtD
Thalidomide—Anxiety—Prednisone—rheumatoid arthritis	3.2e-05	0.000248	CcSEcCtD
Thalidomide—Alopecia—Methotrexate—rheumatoid arthritis	3.2e-05	0.000248	CcSEcCtD
Thalidomide—Insomnia—Dexamethasone—rheumatoid arthritis	3.2e-05	0.000248	CcSEcCtD
Thalidomide—Insomnia—Betamethasone—rheumatoid arthritis	3.2e-05	0.000248	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3.19e-05	0.000247	CcSEcCtD
Thalidomide—Diarrhoea—Cyclosporine—rheumatoid arthritis	3.19e-05	0.000247	CcSEcCtD
Thalidomide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	3.18e-05	0.000246	CcSEcCtD
Thalidomide—Paraesthesia—Dexamethasone—rheumatoid arthritis	3.18e-05	0.000246	CcSEcCtD
Thalidomide—Paraesthesia—Betamethasone—rheumatoid arthritis	3.18e-05	0.000246	CcSEcCtD
Thalidomide—Discomfort—Prednisone—rheumatoid arthritis	3.18e-05	0.000246	CcSEcCtD
Thalidomide—Mental disorder—Methotrexate—rheumatoid arthritis	3.18e-05	0.000246	CcSEcCtD
Thalidomide—Malnutrition—Methotrexate—rheumatoid arthritis	3.16e-05	0.000244	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisolone—rheumatoid arthritis	3.12e-05	0.000242	CcSEcCtD
Thalidomide—Dyspepsia—Betamethasone—rheumatoid arthritis	3.12e-05	0.000241	CcSEcCtD
Thalidomide—Dyspepsia—Dexamethasone—rheumatoid arthritis	3.12e-05	0.000241	CcSEcCtD
Thalidomide—Urticaria—Triamcinolone—rheumatoid arthritis	3.1e-05	0.00024	CcSEcCtD
Thalidomide—Urticaria—Methylprednisolone—rheumatoid arthritis	3.09e-05	0.000239	CcSEcCtD
Thalidomide—Dysgeusia—Methotrexate—rheumatoid arthritis	3.09e-05	0.000239	CcSEcCtD
Thalidomide—Body temperature increased—Triamcinolone—rheumatoid arthritis	3.08e-05	0.000239	CcSEcCtD
Thalidomide—Dizziness—Cyclosporine—rheumatoid arthritis	3.08e-05	0.000239	CcSEcCtD
Thalidomide—Oedema—Prednisone—rheumatoid arthritis	3.08e-05	0.000239	CcSEcCtD
Thalidomide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	3.08e-05	0.000238	CcSEcCtD
Thalidomide—Decreased appetite—Betamethasone—rheumatoid arthritis	3.08e-05	0.000238	CcSEcCtD
Thalidomide—Decreased appetite—Dexamethasone—rheumatoid arthritis	3.08e-05	0.000238	CcSEcCtD
Thalidomide—Infection—Prednisone—rheumatoid arthritis	3.06e-05	0.000237	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	3.06e-05	0.000237	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	3.06e-05	0.000237	CcSEcCtD
Thalidomide—Back pain—Methotrexate—rheumatoid arthritis	3.05e-05	0.000236	CcSEcCtD
Thalidomide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	3.05e-05	0.000236	CcSEcCtD
Thalidomide—Fatigue—Dexamethasone—rheumatoid arthritis	3.05e-05	0.000236	CcSEcCtD
Thalidomide—Fatigue—Betamethasone—rheumatoid arthritis	3.05e-05	0.000236	CcSEcCtD
Thalidomide—Shock—Prednisone—rheumatoid arthritis	3.03e-05	0.000235	CcSEcCtD
Thalidomide—Pain—Betamethasone—rheumatoid arthritis	3.03e-05	0.000234	CcSEcCtD
Thalidomide—Pain—Dexamethasone—rheumatoid arthritis	3.03e-05	0.000234	CcSEcCtD
Thalidomide—Nervous system disorder—Prednisone—rheumatoid arthritis	3.02e-05	0.000234	CcSEcCtD
Thalidomide—Tachycardia—Prednisone—rheumatoid arthritis	3.01e-05	0.000233	CcSEcCtD
Thalidomide—Skin disorder—Prednisone—rheumatoid arthritis	2.99e-05	0.000232	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.98e-05	0.000231	CcSEcCtD
Thalidomide—Vision blurred—Methotrexate—rheumatoid arthritis	2.97e-05	0.00023	CcSEcCtD
Thalidomide—Asthenia—Hydrocortisone—rheumatoid arthritis	2.97e-05	0.00023	CcSEcCtD
Thalidomide—Vomiting—Cyclosporine—rheumatoid arthritis	2.96e-05	0.00023	CcSEcCtD
Thalidomide—Rash—Cyclosporine—rheumatoid arthritis	2.94e-05	0.000228	CcSEcCtD
Thalidomide—Anorexia—Prednisone—rheumatoid arthritis	2.94e-05	0.000228	CcSEcCtD
Thalidomide—Dermatitis—Cyclosporine—rheumatoid arthritis	2.94e-05	0.000227	CcSEcCtD
Thalidomide—Pruritus—Hydrocortisone—rheumatoid arthritis	2.93e-05	0.000227	CcSEcCtD
Thalidomide—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.93e-05	0.000227	CcSEcCtD
Thalidomide—Headache—Cyclosporine—rheumatoid arthritis	2.92e-05	0.000226	CcSEcCtD
Thalidomide—Anaemia—Methotrexate—rheumatoid arthritis	2.92e-05	0.000226	CcSEcCtD
Thalidomide—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.92e-05	0.000226	CcSEcCtD
Thalidomide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000226	CcSEcCtD
Thalidomide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.89e-05	0.000224	CcSEcCtD
Thalidomide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.89e-05	0.000224	CcSEcCtD
Thalidomide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.87e-05	0.000223	CcSEcCtD
Thalidomide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.87e-05	0.000222	CcSEcCtD
Thalidomide—Malaise—Methotrexate—rheumatoid arthritis	2.85e-05	0.00022	CcSEcCtD
Thalidomide—Vertigo—Methotrexate—rheumatoid arthritis	2.84e-05	0.00022	CcSEcCtD
Thalidomide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.83e-05	0.00022	CcSEcCtD
Thalidomide—Leukopenia—Methotrexate—rheumatoid arthritis	2.82e-05	0.000219	CcSEcCtD
Thalidomide—Urticaria—Betamethasone—rheumatoid arthritis	2.81e-05	0.000218	CcSEcCtD
Thalidomide—Urticaria—Dexamethasone—rheumatoid arthritis	2.81e-05	0.000218	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.81e-05	0.000217	CcSEcCtD
Thalidomide—Dizziness—Prednisolone—rheumatoid arthritis	2.8e-05	0.000217	CcSEcCtD
Thalidomide—Asthenia—Triamcinolone—rheumatoid arthritis	2.8e-05	0.000217	CcSEcCtD
Thalidomide—Body temperature increased—Betamethasone—rheumatoid arthritis	2.8e-05	0.000217	CcSEcCtD
Thalidomide—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.8e-05	0.000217	CcSEcCtD
Thalidomide—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.8e-05	0.000217	CcSEcCtD
Thalidomide—Abdominal pain—Betamethasone—rheumatoid arthritis	2.8e-05	0.000217	CcSEcCtD
Thalidomide—Asthenia—Methylprednisolone—rheumatoid arthritis	2.79e-05	0.000216	CcSEcCtD
Thalidomide—Insomnia—Prednisone—rheumatoid arthritis	2.79e-05	0.000216	CcSEcCtD
Thalidomide—Nausea—Cyclosporine—rheumatoid arthritis	2.77e-05	0.000214	CcSEcCtD
Thalidomide—Paraesthesia—Prednisone—rheumatoid arthritis	2.77e-05	0.000214	CcSEcCtD
Thalidomide—Pruritus—Triamcinolone—rheumatoid arthritis	2.76e-05	0.000214	CcSEcCtD
Thalidomide—Cough—Methotrexate—rheumatoid arthritis	2.75e-05	0.000213	CcSEcCtD
Thalidomide—Pruritus—Methylprednisolone—rheumatoid arthritis	2.75e-05	0.000213	CcSEcCtD
Thalidomide—Dizziness—Hydrocortisone—rheumatoid arthritis	2.74e-05	0.000212	CcSEcCtD
Thalidomide—Convulsion—Methotrexate—rheumatoid arthritis	2.73e-05	0.000212	CcSEcCtD
Thalidomide—Dyspepsia—Prednisone—rheumatoid arthritis	2.71e-05	0.00021	CcSEcCtD
Thalidomide—Chest pain—Methotrexate—rheumatoid arthritis	2.69e-05	0.000208	CcSEcCtD
Thalidomide—Myalgia—Methotrexate—rheumatoid arthritis	2.69e-05	0.000208	CcSEcCtD
Thalidomide—Arthralgia—Methotrexate—rheumatoid arthritis	2.69e-05	0.000208	CcSEcCtD
Thalidomide—Decreased appetite—Prednisone—rheumatoid arthritis	2.68e-05	0.000208	CcSEcCtD
Thalidomide—Rash—Prednisolone—rheumatoid arthritis	2.67e-05	0.000207	CcSEcCtD
Thalidomide—Dermatitis—Prednisolone—rheumatoid arthritis	2.67e-05	0.000207	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.67e-05	0.000207	CcSEcCtD
Thalidomide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.66e-05	0.000206	CcSEcCtD
Thalidomide—Fatigue—Prednisone—rheumatoid arthritis	2.66e-05	0.000206	CcSEcCtD
Thalidomide—Headache—Prednisolone—rheumatoid arthritis	2.66e-05	0.000206	CcSEcCtD
Thalidomide—Discomfort—Methotrexate—rheumatoid arthritis	2.65e-05	0.000206	CcSEcCtD
Thalidomide—Constipation—Prednisone—rheumatoid arthritis	2.64e-05	0.000204	CcSEcCtD
Thalidomide—Vomiting—Hydrocortisone—rheumatoid arthritis	2.63e-05	0.000204	CcSEcCtD
Thalidomide—Rash—Hydrocortisone—rheumatoid arthritis	2.61e-05	0.000202	CcSEcCtD
Thalidomide—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.61e-05	0.000202	CcSEcCtD
Thalidomide—Confusional state—Methotrexate—rheumatoid arthritis	2.6e-05	0.000201	CcSEcCtD
Thalidomide—Headache—Hydrocortisone—rheumatoid arthritis	2.59e-05	0.000201	CcSEcCtD
Thalidomide—Dizziness—Triamcinolone—rheumatoid arthritis	2.58e-05	0.0002	CcSEcCtD
Thalidomide—Dizziness—Methylprednisolone—rheumatoid arthritis	2.57e-05	0.000199	CcSEcCtD
Thalidomide—Infection—Methotrexate—rheumatoid arthritis	2.56e-05	0.000198	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisone—rheumatoid arthritis	2.54e-05	0.000197	CcSEcCtD
Thalidomide—Asthenia—Dexamethasone—rheumatoid arthritis	2.54e-05	0.000197	CcSEcCtD
Thalidomide—Asthenia—Betamethasone—rheumatoid arthritis	2.54e-05	0.000197	CcSEcCtD
Thalidomide—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.53e-05	0.000196	CcSEcCtD
Thalidomide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.52e-05	0.000195	CcSEcCtD
Thalidomide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.52e-05	0.000195	CcSEcCtD
Thalidomide—Nausea—Prednisolone—rheumatoid arthritis	2.52e-05	0.000195	CcSEcCtD
Thalidomide—Pruritus—Betamethasone—rheumatoid arthritis	2.5e-05	0.000194	CcSEcCtD
Thalidomide—Pruritus—Dexamethasone—rheumatoid arthritis	2.5e-05	0.000194	CcSEcCtD
Thalidomide—Skin disorder—Methotrexate—rheumatoid arthritis	2.5e-05	0.000194	CcSEcCtD
Thalidomide—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.49e-05	0.000193	CcSEcCtD
Thalidomide—Vomiting—Triamcinolone—rheumatoid arthritis	2.48e-05	0.000192	CcSEcCtD
Thalidomide—Vomiting—Methylprednisolone—rheumatoid arthritis	2.47e-05	0.000192	CcSEcCtD
Thalidomide—Nausea—Hydrocortisone—rheumatoid arthritis	2.46e-05	0.000191	CcSEcCtD
Thalidomide—Rash—Triamcinolone—rheumatoid arthritis	2.46e-05	0.00019	CcSEcCtD
Thalidomide—Dermatitis—Triamcinolone—rheumatoid arthritis	2.46e-05	0.00019	CcSEcCtD
Thalidomide—Anorexia—Methotrexate—rheumatoid arthritis	2.46e-05	0.00019	CcSEcCtD
Thalidomide—Rash—Methylprednisolone—rheumatoid arthritis	2.45e-05	0.00019	CcSEcCtD
Thalidomide—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.45e-05	0.00019	CcSEcCtD
Thalidomide—Urticaria—Prednisone—rheumatoid arthritis	2.45e-05	0.00019	CcSEcCtD
Thalidomide—Headache—Triamcinolone—rheumatoid arthritis	2.44e-05	0.000189	CcSEcCtD
Thalidomide—Headache—Methylprednisolone—rheumatoid arthritis	2.44e-05	0.000189	CcSEcCtD
Thalidomide—Body temperature increased—Prednisone—rheumatoid arthritis	2.44e-05	0.000189	CcSEcCtD
Thalidomide—Abdominal pain—Prednisone—rheumatoid arthritis	2.44e-05	0.000189	CcSEcCtD
Thalidomide—Diarrhoea—Betamethasone—rheumatoid arthritis	2.42e-05	0.000188	CcSEcCtD
Thalidomide—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.42e-05	0.000188	CcSEcCtD
Thalidomide—Hypotension—Methotrexate—rheumatoid arthritis	2.41e-05	0.000186	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.35e-05	0.000182	CcSEcCtD
Thalidomide—Dizziness—Betamethasone—rheumatoid arthritis	2.34e-05	0.000181	CcSEcCtD
Thalidomide—Dizziness—Dexamethasone—rheumatoid arthritis	2.34e-05	0.000181	CcSEcCtD
Thalidomide—Insomnia—Methotrexate—rheumatoid arthritis	2.33e-05	0.00018	CcSEcCtD
Thalidomide—Nausea—Triamcinolone—rheumatoid arthritis	2.32e-05	0.000179	CcSEcCtD
Thalidomide—Paraesthesia—Methotrexate—rheumatoid arthritis	2.31e-05	0.000179	CcSEcCtD
Thalidomide—Nausea—Methylprednisolone—rheumatoid arthritis	2.31e-05	0.000179	CcSEcCtD
Thalidomide—Dyspnoea—Methotrexate—rheumatoid arthritis	2.3e-05	0.000178	CcSEcCtD
Thalidomide—Somnolence—Methotrexate—rheumatoid arthritis	2.29e-05	0.000177	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisone—rheumatoid arthritis	2.27e-05	0.000176	CcSEcCtD
Thalidomide—Dyspepsia—Methotrexate—rheumatoid arthritis	2.27e-05	0.000176	CcSEcCtD
Thalidomide—Vomiting—Betamethasone—rheumatoid arthritis	2.25e-05	0.000174	CcSEcCtD
Thalidomide—Vomiting—Dexamethasone—rheumatoid arthritis	2.25e-05	0.000174	CcSEcCtD
Thalidomide—Decreased appetite—Methotrexate—rheumatoid arthritis	2.24e-05	0.000173	CcSEcCtD
Thalidomide—Rash—Betamethasone—rheumatoid arthritis	2.23e-05	0.000173	CcSEcCtD
Thalidomide—Rash—Dexamethasone—rheumatoid arthritis	2.23e-05	0.000173	CcSEcCtD
Thalidomide—Dermatitis—Betamethasone—rheumatoid arthritis	2.23e-05	0.000173	CcSEcCtD
Thalidomide—Dermatitis—Dexamethasone—rheumatoid arthritis	2.23e-05	0.000173	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.22e-05	0.000172	CcSEcCtD
Thalidomide—Fatigue—Methotrexate—rheumatoid arthritis	2.22e-05	0.000172	CcSEcCtD
Thalidomide—Headache—Betamethasone—rheumatoid arthritis	2.22e-05	0.000172	CcSEcCtD
Thalidomide—Headache—Dexamethasone—rheumatoid arthritis	2.22e-05	0.000172	CcSEcCtD
Thalidomide—Asthenia—Prednisone—rheumatoid arthritis	2.21e-05	0.000171	CcSEcCtD
Thalidomide—Pain—Methotrexate—rheumatoid arthritis	2.2e-05	0.000171	CcSEcCtD
Thalidomide—Pruritus—Prednisone—rheumatoid arthritis	2.18e-05	0.000169	CcSEcCtD
Thalidomide—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.12e-05	0.000164	CcSEcCtD
Thalidomide—Diarrhoea—Prednisone—rheumatoid arthritis	2.11e-05	0.000163	CcSEcCtD
Thalidomide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.11e-05	0.000163	CcSEcCtD
Thalidomide—Nausea—Dexamethasone—rheumatoid arthritis	2.1e-05	0.000163	CcSEcCtD
Thalidomide—Nausea—Betamethasone—rheumatoid arthritis	2.1e-05	0.000163	CcSEcCtD
Thalidomide—Urticaria—Methotrexate—rheumatoid arthritis	2.05e-05	0.000158	CcSEcCtD
Thalidomide—Dizziness—Prednisone—rheumatoid arthritis	2.04e-05	0.000158	CcSEcCtD
Thalidomide—Abdominal pain—Methotrexate—rheumatoid arthritis	2.04e-05	0.000158	CcSEcCtD
Thalidomide—Body temperature increased—Methotrexate—rheumatoid arthritis	2.04e-05	0.000158	CcSEcCtD
Thalidomide—Vomiting—Prednisone—rheumatoid arthritis	1.96e-05	0.000152	CcSEcCtD
Thalidomide—Rash—Prednisone—rheumatoid arthritis	1.94e-05	0.000151	CcSEcCtD
Thalidomide—Dermatitis—Prednisone—rheumatoid arthritis	1.94e-05	0.00015	CcSEcCtD
Thalidomide—Headache—Prednisone—rheumatoid arthritis	1.93e-05	0.00015	CcSEcCtD
Thalidomide—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.9e-05	0.000147	CcSEcCtD
Thalidomide—Asthenia—Methotrexate—rheumatoid arthritis	1.85e-05	0.000143	CcSEcCtD
Thalidomide—Nausea—Prednisone—rheumatoid arthritis	1.83e-05	0.000142	CcSEcCtD
Thalidomide—Pruritus—Methotrexate—rheumatoid arthritis	1.82e-05	0.000141	CcSEcCtD
Thalidomide—Diarrhoea—Methotrexate—rheumatoid arthritis	1.76e-05	0.000136	CcSEcCtD
Thalidomide—Dizziness—Methotrexate—rheumatoid arthritis	1.7e-05	0.000132	CcSEcCtD
Thalidomide—Vomiting—Methotrexate—rheumatoid arthritis	1.64e-05	0.000127	CcSEcCtD
Thalidomide—Rash—Methotrexate—rheumatoid arthritis	1.62e-05	0.000126	CcSEcCtD
Thalidomide—Dermatitis—Methotrexate—rheumatoid arthritis	1.62e-05	0.000126	CcSEcCtD
Thalidomide—Headache—Methotrexate—rheumatoid arthritis	1.61e-05	0.000125	CcSEcCtD
Thalidomide—Nausea—Methotrexate—rheumatoid arthritis	1.53e-05	0.000119	CcSEcCtD
Thalidomide—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	5.73e-06	4.65e-05	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—MAPK8—rheumatoid arthritis	5.72e-06	4.64e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	5.7e-06	4.63e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SLC11A1—rheumatoid arthritis	5.68e-06	4.61e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.68e-06	4.61e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—MTHFR—rheumatoid arthritis	5.65e-06	4.58e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—ICAM1—rheumatoid arthritis	5.64e-06	4.58e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6ST—rheumatoid arthritis	5.64e-06	4.58e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NFATC1—rheumatoid arthritis	5.64e-06	4.57e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—HLA-A—rheumatoid arthritis	5.63e-06	4.57e-05	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—NFKB1—rheumatoid arthritis	5.59e-06	4.53e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TLR4—rheumatoid arthritis	5.58e-06	4.53e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—STAT1—rheumatoid arthritis	5.58e-06	4.53e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HLA-DRB1—rheumatoid arthritis	5.57e-06	4.52e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—GC—rheumatoid arthritis	5.55e-06	4.5e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	5.55e-06	4.5e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	5.53e-06	4.49e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—MED1—rheumatoid arthritis	5.53e-06	4.48e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.51e-06	4.47e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.5e-06	4.46e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SYK—rheumatoid arthritis	5.49e-06	4.46e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ACP5—rheumatoid arthritis	5.45e-06	4.42e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—B3GNT2—rheumatoid arthritis	5.45e-06	4.42e-05	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	5.44e-06	4.41e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ACP5—rheumatoid arthritis	5.44e-06	4.41e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—B3GNT2—rheumatoid arthritis	5.44e-06	4.41e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD80—rheumatoid arthritis	5.43e-06	4.4e-05	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—TNF—rheumatoid arthritis	5.4e-06	4.38e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.39e-06	4.37e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—ICAM1—rheumatoid arthritis	5.35e-06	4.34e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6ST—rheumatoid arthritis	5.35e-06	4.34e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—MMP9—rheumatoid arthritis	5.35e-06	4.34e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.32e-06	4.31e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—STAT1—rheumatoid arthritis	5.3e-06	4.3e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—NFKB1—rheumatoid arthritis	5.29e-06	4.29e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NCF2—rheumatoid arthritis	5.24e-06	4.25e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL10—rheumatoid arthritis	5.22e-06	4.24e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—BGN—rheumatoid arthritis	5.21e-06	4.23e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	5.2e-06	4.22e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	5.16e-06	4.19e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD80—rheumatoid arthritis	5.15e-06	4.18e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—B3GNT2—rheumatoid arthritis	5.14e-06	4.17e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ACP5—rheumatoid arthritis	5.14e-06	4.17e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—GC—rheumatoid arthritis	5.06e-06	4.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	5.06e-06	4.11e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6R—rheumatoid arthritis	5.03e-06	4.08e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP3—rheumatoid arthritis	5.02e-06	4.07e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6ST—rheumatoid arthritis	4.94e-06	4.01e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ENO1—rheumatoid arthritis	4.93e-06	4e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—BGN—rheumatoid arthritis	4.91e-06	3.98e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NOS2—rheumatoid arthritis	4.9e-06	3.98e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—BGN—rheumatoid arthritis	4.9e-06	3.97e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	4.89e-06	3.97e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.85e-06	3.93e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—PTK2—rheumatoid arthritis	4.83e-06	3.92e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SAA1—rheumatoid arthritis	4.82e-06	3.91e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—VEGFA—rheumatoid arthritis	4.8e-06	3.89e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	4.8e-06	3.89e-05	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	4.8e-06	3.89e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6R—rheumatoid arthritis	4.77e-06	3.87e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP3—rheumatoid arthritis	4.76e-06	3.86e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD80—rheumatoid arthritis	4.76e-06	3.86e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCL5—rheumatoid arthritis	4.74e-06	3.84e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	4.73e-06	3.84e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NCF1—rheumatoid arthritis	4.72e-06	3.83e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	4.7e-06	3.82e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ENO1—rheumatoid arthritis	4.67e-06	3.79e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CSF2—rheumatoid arthritis	4.67e-06	3.79e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—BGN—rheumatoid arthritis	4.63e-06	3.75e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—PTK2—rheumatoid arthritis	4.58e-06	3.72e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—TYK2—rheumatoid arthritis	4.58e-06	3.72e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD28—rheumatoid arthritis	4.54e-06	3.68e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—MED1—rheumatoid arthritis	4.52e-06	3.67e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ALOX5—rheumatoid arthritis	4.52e-06	3.66e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	4.51e-06	3.66e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCL5—rheumatoid arthritis	4.49e-06	3.65e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	4.44e-06	3.61e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CSF2—rheumatoid arthritis	4.43e-06	3.59e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6R—rheumatoid arthritis	4.41e-06	3.58e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—TGFB1—rheumatoid arthritis	4.41e-06	3.57e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—SPP1—rheumatoid arthritis	4.39e-06	3.56e-05	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—IL6—rheumatoid arthritis	4.36e-06	3.54e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—TYK2—rheumatoid arthritis	4.35e-06	3.53e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—GC—rheumatoid arthritis	4.32e-06	3.51e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	4.32e-06	3.51e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IFNG—rheumatoid arthritis	4.29e-06	3.48e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—UBE2D1—rheumatoid arthritis	4.27e-06	3.47e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCR5—rheumatoid arthritis	4.27e-06	3.46e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ALOX5—rheumatoid arthritis	4.26e-06	3.45e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.24e-06	3.44e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.22e-06	3.42e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	4.21e-06	3.41e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	4.21e-06	3.41e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2RA—rheumatoid arthritis	4.21e-06	3.41e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—C3—rheumatoid arthritis	4.17e-06	3.38e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SPP1—rheumatoid arthritis	4.16e-06	3.38e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD4—rheumatoid arthritis	4.14e-06	3.36e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—ADRBK1—rheumatoid arthritis	4.14e-06	3.36e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—MED1—rheumatoid arthritis	4.12e-06	3.35e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IFNG—rheumatoid arthritis	4.07e-06	3.3e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCR5—rheumatoid arthritis	4.05e-06	3.28e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	4.02e-06	3.26e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TYK2—rheumatoid arthritis	4.01e-06	3.26e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2RA—rheumatoid arthritis	3.99e-06	3.24e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—C3—rheumatoid arthritis	3.96e-06	3.21e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NOS3—rheumatoid arthritis	3.94e-06	3.2e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—rheumatoid arthritis	3.93e-06	3.19e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ENO1—rheumatoid arthritis	3.91e-06	3.17e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—LEP—rheumatoid arthritis	3.88e-06	3.15e-05	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—IL6—rheumatoid arthritis	3.85e-06	3.12e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.85e-06	3.12e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	3.83e-06	3.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	3.83e-06	3.11e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL1B—rheumatoid arthritis	3.83e-06	3.11e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PRKCQ—rheumatoid arthritis	3.82e-06	3.1e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL2—rheumatoid arthritis	3.81e-06	3.09e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—BGN—rheumatoid arthritis	3.79e-06	3.07e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—STAT1—rheumatoid arthritis	3.76e-06	3.05e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.74e-06	3.04e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—LEP—rheumatoid arthritis	3.68e-06	2.99e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ENO1—rheumatoid arthritis	3.68e-06	2.99e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	3.67e-06	2.98e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—FN1—rheumatoid arthritis	3.66e-06	2.97e-05	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—IL6—rheumatoid arthritis	3.65e-06	2.96e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.65e-06	2.96e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL1B—rheumatoid arthritis	3.63e-06	2.95e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—rheumatoid arthritis	3.63e-06	2.95e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL2—rheumatoid arthritis	3.62e-06	2.94e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTGS2—rheumatoid arthritis	3.6e-06	2.92e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CAT—rheumatoid arthritis	3.55e-06	2.88e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—MED1—rheumatoid arthritis	3.52e-06	2.86e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—MAPK8—rheumatoid arthritis	3.51e-06	2.85e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CD80—rheumatoid arthritis	3.51e-06	2.85e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	3.48e-06	2.83e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—FN1—rheumatoid arthritis	3.47e-06	2.82e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ENO1—rheumatoid arthritis	3.47e-06	2.82e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6ST—rheumatoid arthritis	3.46e-06	2.81e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—BGN—rheumatoid arthritis	3.45e-06	2.8e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.41e-06	2.77e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NFKB1—rheumatoid arthritis	3.39e-06	2.75e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—POMC—rheumatoid arthritis	3.33e-06	2.71e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—MAPK8—rheumatoid arthritis	3.33e-06	2.7e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CD80—rheumatoid arthritis	3.33e-06	2.7e-05	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—IL6—rheumatoid arthritis	3.32e-06	2.69e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	3.28e-06	2.66e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	3.28e-06	2.66e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CCL2—rheumatoid arthritis	3.26e-06	2.65e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6R—rheumatoid arthritis	3.25e-06	2.64e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	3.18e-06	2.58e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—POMC—rheumatoid arthritis	3.16e-06	2.57e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CCL2—rheumatoid arthritis	3.1e-06	2.51e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6R—rheumatoid arthritis	3.09e-06	2.5e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.06e-06	2.49e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.99e-06	2.42e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TYK2—rheumatoid arthritis	2.96e-06	2.4e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	2.96e-06	2.4e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—BGN—rheumatoid arthritis	2.95e-06	2.39e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—NOS3—rheumatoid arthritis	2.91e-06	2.36e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CCR5—rheumatoid arthritis	2.87e-06	2.33e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.84e-06	2.3e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CAT—rheumatoid arthritis	2.82e-06	2.28e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TYK2—rheumatoid arthritis	2.81e-06	2.28e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—MTHFR—rheumatoid arthritis	2.81e-06	2.28e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—HLA-A—rheumatoid arthritis	2.8e-06	2.27e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.79e-06	2.27e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.79e-06	2.27e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NOS3—rheumatoid arthritis	2.76e-06	2.24e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.72e-06	2.2e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CAT—rheumatoid arthritis	2.65e-06	2.15e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CAT—rheumatoid arthritis	2.64e-06	2.15e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—TGFB1—rheumatoid arthritis	2.61e-06	2.11e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.59e-06	2.1e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.58e-06	2.09e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.55e-06	2.07e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CAT—rheumatoid arthritis	2.5e-06	2.03e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2—rheumatoid arthritis	2.47e-06	2e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6ST—rheumatoid arthritis	2.45e-06	1.99e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL8—rheumatoid arthritis	2.45e-06	1.99e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.44e-06	1.98e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS2—rheumatoid arthritis	2.43e-06	1.97e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.39e-06	1.94e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—POMC—rheumatoid arthritis	2.37e-06	1.92e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD80—rheumatoid arthritis	2.36e-06	1.92e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	2.35e-06	1.91e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2—rheumatoid arthritis	2.34e-06	1.9e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MMP9—rheumatoid arthritis	2.33e-06	1.89e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.27e-06	1.84e-05	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL6—rheumatoid arthritis	2.24e-06	1.82e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.23e-06	1.81e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MMP9—rheumatoid arthritis	2.21e-06	1.8e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.21e-06	1.8e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—MTHFR—rheumatoid arthritis	2.21e-06	1.79e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	2.21e-06	1.79e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—NFKB1—rheumatoid arthritis	2.19e-06	1.78e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6R—rheumatoid arthritis	2.19e-06	1.78e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.18e-06	1.77e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—ALB—rheumatoid arthritis	2.16e-06	1.75e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—MAPK8—rheumatoid arthritis	2.15e-06	1.75e-05	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL6—rheumatoid arthritis	2.13e-06	1.73e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.1e-06	1.7e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—MTHFR—rheumatoid arthritis	2.09e-06	1.69e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—NOS3—rheumatoid arthritis	2.06e-06	1.67e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CAT—rheumatoid arthritis	2.04e-06	1.66e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TYK2—rheumatoid arthritis	1.99e-06	1.62e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.99e-06	1.61e-05	CbGpPWpGaD
Thalidomide—FGFR2—Disease—IL6—rheumatoid arthritis	1.96e-06	1.59e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NOS3—rheumatoid arthritis	1.96e-06	1.59e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.92e-06	1.56e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.9e-06	1.55e-05	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	1.89e-06	1.53e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—POMC—rheumatoid arthritis	1.88e-06	1.52e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.86e-06	1.51e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.82e-06	1.48e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—rheumatoid arthritis	1.8e-06	1.46e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—POMC—rheumatoid arthritis	1.77e-06	1.44e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.77e-06	1.43e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ALB—rheumatoid arthritis	1.71e-06	1.39e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.71e-06	1.38e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—POMC—rheumatoid arthritis	1.67e-06	1.35e-05	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NOS3—rheumatoid arthritis	1.64e-06	1.33e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ALB—rheumatoid arthritis	1.61e-06	1.31e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.61e-06	1.31e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.59e-06	1.29e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TP53—rheumatoid arthritis	1.58e-06	1.28e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.56e-06	1.26e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NOS3—rheumatoid arthritis	1.54e-06	1.25e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	1.54e-06	1.25e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ALB—rheumatoid arthritis	1.52e-06	1.23e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TP53—rheumatoid arthritis	1.5e-06	1.22e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NOS3—rheumatoid arthritis	1.45e-06	1.18e-05	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL6—rheumatoid arthritis	1.45e-06	1.18e-05	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS2—rheumatoid arthritis	1.41e-06	1.14e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	1.41e-06	1.14e-05	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL6—rheumatoid arthritis	1.37e-06	1.12e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.36e-06	1.11e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS2—rheumatoid arthritis	1.33e-06	1.08e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.33e-06	1.08e-05	CbGpPWpGaD
Thalidomide—PTGS2—Disease—TGFB1—rheumatoid arthritis	1.29e-06	1.05e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.24e-06	1.01e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1.24e-06	1.01e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	1.19e-06	9.66e-06	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.13e-06	9.2e-06	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	1.09e-06	8.83e-06	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.09e-06	8.81e-06	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.06e-06	8.63e-06	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	9.93e-07	8.05e-06	CbGpPWpGaD
Thalidomide—PTGS2—Disease—IL6—rheumatoid arthritis	9.75e-07	7.91e-06	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ALB—rheumatoid arthritis	9.7e-07	7.87e-06	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	9.27e-07	7.52e-06	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	8.48e-07	6.88e-06	CbGpPWpGaD
